Evidence map›Paper›PMID 32341162›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Quantitative analysis of amino acid metabolism in liver cancer links glutamate excretion to nucleotide synthesis.

Avlant Nilsson, Jurgen R Haanstra, Martin Engqvist, Albert Gerding, Barbara M Bakker, Ursula Klingmüller, Bas Teusink, Jens Nielsen

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Avlant NilssonDepartment of Biology and Biological Engineering, Chalmers University of Technology, SE41296 Gothenburg, Sweden.ORCID 0000-0002-9476-4516
Jurgen R HaanstraSystems Biology Lab, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, NL1081HZ Amsterdam, The Netherlands.ORCID 0000-0001-9652-0219
Martin EngqvistDepartment of Biology and Biological Engineering, Chalmers University of Technology, SE41296 Gothenburg, Sweden.ORCID 0000-0003-2174-2225
Albert GerdingLaboratory of Pediatrics, Systems Medicine of Metabolism and Signaling, University of Groningen, University Medical Center Groningen, NL-9713AV Groningen, The Netherlands.ORCID 0000-0002-6004-2398
Barbara M BakkerSystems Biology Lab, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, NL1081HZ Amsterdam, The Netherlands.ORCID 0000-0001-6274-3633
Ursula KlingmüllerDivision of Systems Biology and Signal Transduction, German Cancer Research Center, D-69120 Heidelberg, Germany.ORCID 0000-0001-9845-3099
Bas TeusinkSystems Biology Lab, Amsterdam Institute of Molecular and Life Sciences (AIMMS), Vrije Universiteit Amsterdam, NL1081HZ Amsterdam, The Netherlands.ORCID 0000-0003-3929-0423
Jens NielsenDepartment of Biology and Biological Engineering, Chalmers University of Technology, SE41296 Gothenburg, Sweden; nielsenj@chalmers.se.ORCID 0000-0002-9955-6003
Chalmers University of Technology · SEUniversity Medical Center Groningen · NLVrije Universiteit Amsterdam · NLGerman Cancer Research Center · DENovo Nordisk Foundation · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many cancer cells consume glutamine at high rates; counterintuitively, they simultaneously excrete glutamate, the first intermediate in glutamine metabolism. Glutamine consumption has been linked to replenishment of tricarboxylic acid cycle (TCA) intermediates and synthesis of adenosine triphosphate (ATP), but the reason for glutamate excretion is unclear. Here, we dynamically profile the uptake and excretion fluxes of a liver cancer cell line (HepG2) and use genome-scale metabolic modeling for in-depth analysis. We find that up to 30% of the glutamine is metabolized in the cytosol, primarily for nucleotide synthesis, producing cytosolic glutamate. We hypothesize that excreting glutamate helps the cell to increase the nucleotide synthesis rate to sustain growth. Indeed, we show experimentally that partial inhibition of glutamate excretion reduces cell growth. Our integrative approach thus links glutamine addiction to glutamate excretion in cancer and points toward potential drug targets.

Indexed as

Adenosine TriphosphateCarcinoma, HepatocellularCells, CulturedCitric Acid CycleCytosolEnergy MetabolismGlutamic AcidGlutamineHep G2 CellsHumansLiver NeoplasmsMitochondriaAdenosine TriphosphateGlutamic AcidGlutamineflux-balance analysisgenome-scale modelingmetabolic engineeringsystems biology

Identifiers

PMID32341162
PMCPMC7229649
OpenAlexW3018608736

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.